Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV.
Saved in:
| Title: | Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV. |
|---|---|
| Authors: | Edwards S; School of Public Health, The University of Queensland, Brisbane, Australia., Puljević C; School of Public Health, The University of Queensland, Brisbane, Australia.; Centre for Health Services Research, The University of Queensland, Brisbane, Australia., Dean JA; School of Public Health, The University of Queensland, Brisbane, Australia., Gilks C; School of Public Health, The University of Queensland, Brisbane, Australia., Boyd MA; Faculty of Health & Medical Sciences, University of Adelaide, Adelaide, Australia.; Northern Adelaide Local Health Network (NALHN), Adelaide, Australia.; Kirby Institute, University of New South Wales, Sydney, Australia., Baker P; School of Public Health, The University of Queensland, Brisbane, Australia., Watts P; Queensland Positive People, Brisbane, Australia., Howard C; Queensland Positive People, Brisbane, Australia., Gartner CE; School of Public Health, The University of Queensland, Brisbane, Australia. c.gartner@uq.edu.au. |
| Source: | AIDS and behavior [AIDS Behav] 2023 Feb; Vol. 27 (2), pp. 618-627. Date of Electronic Publication: 2022 Jul 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9712133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3254 (Electronic) Linking ISSN: 10907165 NLM ISO Abbreviation: AIDS Behav Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
